AngioDynamics, Inc. - Common Stock — Balance Sheet (NASDAQ:ANGO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 561.44 M552.75 M532.64 M317.67 M280.14 M267.16 M Total liabilities 121.98 M128.26 M154.34 M112.08 M97.17 M96.34 M Total equity 439.46 M424.49 M378.3 M205.59 M182.97 M170.82 M Total liabilities & shareholders' equities 561.44 M552.75 M532.64 M317.67 M280.14 M267.16 M Total debt —————— Net debt ——————

News

AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?

AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In

AngioDynamics: Growth Is Working, Price Knows It (Downgrade) (NASDAQ:ANGO)

AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands

AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call Transcript

AngioDynamics, Inc. 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:ANGO) 2026-07-14

AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study